Albemarle (ALB) Misses Q3 EPS by 105c; offers guidance
Get Alerts ALB Hot Sheet
Price: $126.28 -4.45%
Revenue Growth %: +19.1%
Financial Fact:
Net income attributable to Albemarle Corporation: 128.22M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +19.1%
Financial Fact:
Net income attributable to Albemarle Corporation: 128.22M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Albemarle (NYSE: ALB) reported Q3 EPS of $2.74, $1.05 worse than the analyst estimate of $3.79. Revenue for the quarter came in at $2.31 billion versus the consensus estimate of $2.53 billion.
GUIDANCE:
Albemarle sees FY2023 EPS of $21.50-$23.50, versus the consensus of $25.99. Albemarle sees FY2023 revenue of $9.5-9.8 billion, versus the consensus of $10.246 billion.
For earnings history and earnings-related data on Albemarle (ALB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
- Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share